Literature DB >> 1086325

Reversal of cell surface abnormalities of T lymphocytes in hodgkin's disease after in vitro incubation in fetal sera.

Z Fuks, S Strober, D P King, H S Kaplan.   

Abstract

The capacity of periphal blood lymphocytes from patients with untreated Hodgkin's disease to form E rosettes with sheep erythrocytes and to respond in vitro to PHA stimulation were found to be profoundly impaired. In 49% of the patients, the percentage of E rosette-forming cells (E-RFC) was more than two standard deviations below the mean for normal donors. Overnight incubation of the peripheral blood lymhocytes from these patients in culture media containing 20% fetal calf serum was followed by restoration of the percentage of E-RFC up to normal levels. Similar results have been observed after incubation in fetal human serum, but not in adult human AB serum or adult bovine serum. Incubation of peripheral blood lymphocytes from untreated patients in20% fetal calf serum also resulted in a remarkable restoration of their capacity to respond normally to PHA. Possible mechanisms involved in these reversible cell surface and in vitro lymphocyte function abnormalities in Hodgkin's disease are discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1086325

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  E-rosette inhibiting substance in Hodgkin's disease spleen extracts.

Authors:  M M Bieber; Z Fuks; H S Kaplan
Journal:  Clin Exp Immunol       Date:  1977-09       Impact factor: 4.330

Review 2.  Hodgkin's disease and anergy.

Authors:  T A Shiftan; J Mendelsohn
Journal:  Blut       Date:  1979-01-22

3.  Immunorestorative properties of thymostimulin (TS) in patients with Hodgkin's disease in clinical remission.

Authors:  A M Liberati; M Brugia; B S Edwards; P Bertoni; E Ballatori; A Puxeddu; F Grignani
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

4.  Bovine lymphocytes: enhanced E-rosette formation after storage or gradient centrifugation.

Authors:  D A Higgins; M J Stack
Journal:  Clin Exp Immunol       Date:  1977-08       Impact factor: 4.330

5.  Lymphocyte subsets and natural killer cell responses during cytomegalovirus mononucleosis.

Authors:  C R Rinaldo; M Ho; W H Hamoudi; X E Gui; R L DeBiasio
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

6.  Absence of IgG lymphocytotoxins in untreated Hodgkin's disease (HD) patients.

Authors:  D B Jones; E V Elliott; S V Payne; D H Wright
Journal:  Clin Exp Immunol       Date:  1978-10       Impact factor: 4.330

7.  Autologous mixed lymphocyte reaction in patients with Hodgkin's disease. Evidence for a T cell defect.

Authors:  E G Engleman; C J Benike; R T Hoppe; H S Kaplan; F R Berberich
Journal:  J Clin Invest       Date:  1980-07       Impact factor: 14.808

8.  Evaluation of the circulating and splenic lymphocyte subpopulations in patients with non-Hodgkin lymphomas and Hodgkin's disease using monoclonal antibodies.

Authors:  F Herrmann; G Sieber; B Jauer; A Lochner; B Komischke; H Rühl
Journal:  Blut       Date:  1983-07

9.  Mitogen responsiveness in viral hepatitis and chronic active hepatitis: the role of reversible suppressive influences.

Authors:  C Feighery; J F Greally; D G Weir
Journal:  Gut       Date:  1980-09       Impact factor: 23.059

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.